BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23228708)

  • 1. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
    Chargari C; Moncharmont C; Lévy A; Guy JB; Bertrand G; Guilbert M; Rousseau C; Védrine L; Alphonse G; Toillon RA; Rodriguez-Lafrasse C; Deutsch E; Magné N
    Bull Cancer; 2012 Dec; 99(12):1153-60. PubMed ID: 23228708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer: stem cells and brain tumours.
    Dirks PB
    Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
    [No Abstract]   [Full Text] [Related]  

  • 3. Notch promotes radioresistance of glioma stem cells.
    Wang J; Wakeman TP; Lathia JD; Hjelmeland AB; Wang XF; White RR; Rich JN; Sullenger BA
    Stem Cells; 2010 Jan; 28(1):17-28. PubMed ID: 19921751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting brain-tumor stem cells.
    Stupp R; Hegi ME
    Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
    [No Abstract]   [Full Text] [Related]  

  • 7. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
    Wang L; Long L; Wang W; Liang Z
    J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
    Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
    Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.
    Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO
    Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
    Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
    Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
    Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
    McCord AM; Jamal M; Williams ES; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2009 Aug; 15(16):5145-53. PubMed ID: 19671863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.
    Sheehan JP; Shaffrey ME; Gupta B; Larner J; Rich JN; Park DM
    Future Oncol; 2010 Oct; 6(10):1591-601. PubMed ID: 21062158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells and radiotherapy: new insights into tumor radioresistance.
    Diehn M; Clarke MF
    J Natl Cancer Inst; 2006 Dec; 98(24):1755-7. PubMed ID: 17179471
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma cancer stem cells--from concept to clinical application.
    Stopschinski BE; Beier CP; Beier D
    Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.